Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KR230109 cream in acne vulgaris
NCT07345390Phase 2Not yet recruiting
- Sponsor
- Jiangxi Kvvit Pharmaceutical
- Start
- Jan 2026
- Primary completion
- Oct 2026
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of KR230109 in acne vulgaris, sponsored by Jiangxi Kvvit Pharmaceutical. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
KR230109
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT07345390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07345390.